5 Minutes Read
Alembic Pharmaceuticals receives USFDA inspection report for oncology unit in Gujarat
KV Prasad Jun 13, 2022, 06:35 AM IST (Published)
Listen to the Article (6 Minutes)
Summary
The inspection was carried out at the pharmaceutical company’s formulation facility from February 28 to March 8.
Alembic Pharmaceuticals on Monday, May 6, announced that it has received an establishment inspection report (EIR) from the United States Food and Drug Administration for its oncology facility in Gujarat.
The pharma company, in a stock exchange filing, said that its oncology (injectable and oral solid) formulation facility located at Panelav in Panch Mahals district of Gujarat has received the EIR from the US drug regulator.
“The company has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for the inspection carried out by them at our Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav,” the company said.
The inspection was carried out at the pharmaceutical company’s formulation facility from February 28 to March 8. The company also informed the bourses that the EIRs are in place for all of its USFDA facilities.
Alembic Pharma is all set to declare its results for the fourth quarter of FY24, the company has informed the bourses via a release that it will declare its results on Thursday, May 9.
“A meeting of Board of Directors of the company will be held on Thursday, May 9, 2024, inter-alia to transact the following business: To consider and approve Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2024,” the company informed the bourses.
The pharma major also said that it will consider and recommend a dividend if any for FY24 in the meeting.
“To consider and recommend dividend on equity shares, if any, for the financial year ended March 31, 2024,” the company said.
Alembic Pharmaceuticals Ltd shares were trading 0.87% lower at ₹1,017.25 apiece on the BSE at 10:42 am.
Catch live market updates with CNBC-TV18.com’s blog
Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout
3 Mins Read
Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter
Daily Newsletter
